SCHEMBL24492829

SCHEMBL24492829

c1ccc(-c2cc(-c3cccc(-c4cccc(-c5cccc(-c6ccncc6)c5)c4)c3)cc(-c3cccc(-c4cccc(-c5cccc(-c6ccncc6)c5)c4)c3)c2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.75
PRKCI P41743 1/20 0.55
KIF11 P52732 1/20 0.55
MAPT P10636 2/20 0.55
LMNA P02545 1/20 0.55
MKNK1 Q9BUB5 1/20 0.52
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
ATAD2 Q6PL18 1/20 0.50
PIK3CA P42336 1/20 0.50
PRMT6 Q96LA8 1/20 0.50
IMPDH2 P12268 1/20 0.49
MAPK13 O15264 1/20 0.47
GCGR P47871 1/20 0.47
MAPK12 P53778 1/20 0.47
MAPK11 Q15759 1/20 0.47
MAPK14 Q16539 1/20 0.47
KDR P35968 1/20 0.47
NISCH Q9Y2I1 1/20 0.47
QDPR P09417 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17721058 1.00 NOTUM (0.75) NOTUMPRKCIKIF11MAPTLMNA
SCHEMBL18134301 1.00 NOTUM (0.75) NOTUMPRKCIKIF11MAPTLMNA
SCHEMBL17189944 1.00 NOTUM (0.75) NOTUMPRKCIKIF11MAPTLMNA
SCHEMBL22428538 1.00 NOTUM (0.75) NOTUMPRKCIKIF11MAPTLMNA
SCHEMBL18650164 1.00 NOTUM (0.75) NOTUMPRKCIKIF11MAPTLMNA
SCHEMBL18134276 1.00 NOTUM (0.75) NOTUMPRKCIKIF11MAPTLMNA
SCHEMBL18134275 1.00 NOTUM (0.75) NOTUMPRKCIKIF11MAPTLMNA
SCHEMBL18650170 0.98 NOTUM (0.71) NOTUMPRKCIKIF11MAPTLMNA
SCHEMBL18134296 0.98 NOTUM (0.71) NOTUMPRKCIKIF11MAPTLMNA
SCHEMBL18650186 0.98 NOTUM (0.71) NOTUMPRKCIKIF11MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2022-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT ETV6, LEF1, TEAD2 NOTUM 1061/4885PRKCI 4856/4885KIF11 4326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.